Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

733.70
-1.1100-0.15%
Volume:350.06K
Turnover:257.31M
Market Cap:75.54B
PE:18.15
High:742.50
Open:740.00
Low:729.20
Close:734.81
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.41
T/O Rate:0.35%
Dividend:3.64
Dividend Rate:0.50%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.38
PE(LYR):17.69

Loading ...

Regeneron Pharmaceuticals, - Lower Doses of Trevogrumab Well Tolerated with 77% Experiencing at Least One Adverse Event

THOMSON REUTERS
·
Oct 01

Regeneron Pharmaceuticals, - Plans Phase 2 Trial of Trevogrumab with Glp-1 Therapies in Older Adults

THOMSON REUTERS
·
Oct 01

Phase 2 Courage Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During Glp-1 Receptor Agonist-Induced Weight Loss

THOMSON REUTERS
·
Oct 01

Regeneron Pharmaceuticals, - Trevogrumab Prevents 70% of Muscle Loss Associated with Semaglutide Treatment

THOMSON REUTERS
·
Oct 01

Movement Alert|Regeneron Pharmaceuticals Falls 3.08% in Regular Trading, Expanded Sanofi Alliance Fails to Meet Investor Expectations on Deal Terms

Market Focus
·
Oct 01

Regeneron Exec Says Co Eligible to Receive $1 Bln in Potential Milestone Payment with the Start of the First Late-Stage Trial as Part of the Deal -Conf Call

THOMSON REUTERS
·
Oct 01

Regeneron Exec Says Co Expects to Start Pivotal Study for Regn20423 Either in Late 2027 or Early 2028

THOMSON REUTERS
·
Oct 01

Regeneron Pharma Price Target Announced at $850.00/Share by Argus Research

Dow Jones
·
Oct 01

Sanofi Exec Says "There is no Certainty at This Point in Time, but We are Actively Working in Order to Extend the Loss of Exclusivity of Dupixent"

THOMSON REUTERS
·
Oct 01

Sanofi CEO Says Expects the Market for Atopic Dermatitis Treatments to Nearly Double over the Next Five Years -Conf Call

THOMSON REUTERS
·
Oct 01

Argus Upgrades Regeneron Pharmaceuticals to Buy From Hold, Price Target is $850

MT Newswires Live
·
Oct 01

Regeneron Pharmaceuticals, Inc. : Argus Research Raises to Buy from Hold

THOMSON REUTERS
·
Oct 01

Stocks to Watch: Micron, Alphabet, Sanofi, Nu Holdings

Dow Jones
·
Oct 01

Sanofi’s Regeneron Fix Requires Extra Shot of M&A

Reuters
·
Oct 01

Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook

Dow Jones
·
Oct 01

Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance

Dow Jones
·
Oct 01

Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute

Reuters
·
Oct 01

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Reuters
·
Oct 01

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Reuters
·
Oct 01

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS
·
Oct 01